(Q35001011)

English

A Rho-kinase inhibitor, soluble guanylate cyclase activator and nitric oxide-releasing PDE5 inhibitor: novel approaches to erectile dysfunction

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

A Rho-kinase inhibitor, soluble guanylate cyclase activator and nitric oxide-releasing PDE5 inhibitor: novel approaches to erectile dysfunction (English)

1 reference

Europe PubMed Central

5 August 2017

1 reference

ORCID Public Data File 2021

author name string

Selim Cellek

1

1 reference

Europe PubMed Central

5 August 2017

Rowland W Rees

2

1 reference

Europe PubMed Central

5 August 2017

Jas Kalsi

3

1 reference

Europe PubMed Central

5 August 2017

language of work or name

0 references

publication date

1 November 2002

1 reference

Europe PubMed Central

5 August 2017

Expert Opinion on Investigational Drugs

1 reference

Europe PubMed Central

5 August 2017

11

1 reference

Europe PubMed Central

5 August 2017

11

1 reference

Europe PubMed Central

5 August 2017

1563-1573

1 reference

Europe PubMed Central

5 August 2017

Inositol trisphosphate and calcium signalling

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Ibeta

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

Selective nitrergic neurodegeneration in diabetes mellitus - a nitric oxide-dependent phenomenon

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

Update on male erectile dysfunction

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

Diabetic sexual dysfunction

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

Effects of diabetes on nitric oxide synthase and growth factor genes and protein expression in an animal model.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

Hemodynamic insult by vascular risk factors and pharmacologic erection in men with erectile dysfunction: Doppler sonography study.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

Corporeal structural and vascular micro architecture with X-ray micro computerized tomography in normal and diabetic rabbits: histopathological correlation

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

The small GTPase Rho: cellular functions and signal transduction

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

Identification of a putative target for Rho as the serine-threonine kinase protein kinase N

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

Role of citron kinase as a target of the small GTPase Rho in cytokinesis

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

p140mDia, a mammalian homolog of Drosophila diaphanous, is a target protein for Rho small GTPase and is a ligand for profilin

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

The effects of the Rho-kinase inhibitor Y-27632 on arachidonic acid-, GTPgammaS-, and phorbol ester-induced Ca2+-sensitization of smooth muscle

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

Evaluation of Y-27632, a rho-kinase inhibitor, as a bronchodilator in guinea pigs.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

Inhibition of sustained hypoxic vasoconstriction by Y-27632 in isolated intrapulmonary arteries and perfused lung of the rat.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

Inhibition of Rho-associated kinase blocks agonist-induced Ca2+ sensitization of myosin phosphorylation and force in guinea-pig ileum

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

Evidence that Rho-kinase activity contributes to cerebral vascular tone in vivo and is enhanced during chronic hypertension: comparison with protein kinase C.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

Reduction of intraocular pressure by topical administration of an inhibitor of the Rho-associated protein kinase

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

RhoA-mediated Ca2+ sensitization in erectile function

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

Y-27632, an inhibitor of Rho-kinase, antagonizes noradrenergic contractions in the rabbit and human penile corpus cavernosum

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

Soluble guanylate cyclase: an old therapeutic target re-visited.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

NO-independent regulatory site on soluble guanylate cyclase

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

NO-independent regulatory site of direct sGC stimulators like YC-1 and BAY 41-2272

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

NO-independent stimulators of soluble guanylate cyclase

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

Cardiovascular actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vivo studies

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

Activation of soluble guanylate cyclase causes relaxation of corpus cavernosum tissue: synergism of nitric oxide and YC-1.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1563

21 January 2018

Identifiers

10.1517/13543784.11.11.1563

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35001011&oldid=1971115496"